The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.
Issue link: https://lifescienceleadermag.epubxp.com/i/111709
ABC (Analytical Bio-Chemistry) Laboratories, Inc. www.abclabs.com ��� (888) 222-4331 key locations: Columbia, MO and Sacramento, CA contact: Kristein King ��� kingk@abclabs.com Drug Life Cycle Stages: Research & Development ��� Discovery, Preclinical, Clinical (Phase 1, Phase 2, and Phase 3) Formulated Drug Production: Dosage Form Development ��� Columbia, MO Main Service Areas: Bioanalytical, Clinical, Preclinical SERVICES & CAPABILITIES: Full CMC support for large and small molecule programs including method development & validation, characterization, extractables & leachables, stability services, quality control testing, plus bioanalytical services, radiolabeling & custom synthesis, and environmental assessments. THERAPEUTIC AREAS: ABC provides development expertise and analytical support for pharmaceuticals and biopharmaceuticals across all therapeutic areas, with particular expertise with inhalation and cytotoxic drug products, as well as those with complex delivery systems. ���It is very rewarding to be recognized as a quality leader by our clients. We serve an industry whose fundamental purpose is improving quality of life, and feel fortunate to be part of that mission. The demand for quality systems, regulatory rigor, and a commitment to continuous improvement is sure to intensify in the years ahead. ABC is committed to meeting that challenge.��� ��� John Bucksath, president & CEO Acceleration Laboratory Services, Inc. ��� Lees Summit, MO www.accelerationkc.com ��� (816) 525-1150 key locations: Lees Summit, MO contact: Robert Poe, MBA ��� rpoe@accelerationkc.com Drug Life Cycle Stages: Research & Development ��� Preclinical, Clinical (Phase 1, Phase 2, and Phase 3) Drug Substance Production Formulated Drug Production: Dosage Form Development, Dosage Form Production, Packaging Main Service Areas: Clinical, Preclinical SERVICES & CAPABILITIES: Acceleration provides support for clinical trials in method development and validation of methods for analysis and release of clinical dosage formulations. Preclinical support is provided in characterization of API, formulation support, and tox dose analysis. THERAPEUTIC AREAS: Acceleration supports all therapeutic areas, but has extensive experience in working with oncolytics, cytoxics, and other highly potent compounds. KEY INDUSTRY PARTNERS: Polsinelli Shugart PC, Xenometrics, LLC, PRA International, and Xcelience ���Acceleration scored highly in the category of reliability for one pure and simple reason, our associates. The team at Acceleration is highly experienced, many with extensive large pharma experience. As a contract solutions provider, this gives us the unique perspective of fully understanding the challenges our clients face in the drug development process. We work side by side with our client to determine the best path forward. Then we do what we say we will do.��� ��� Brent Taylor, general manager Agilux Laboratories ��� Worcester, MA www.agiluxlabs.com ��� (508) 753-5000 contact: Steven Guyan ��� sguyan@agiluxlabs.com Drug Life Cycle Stages: Research & Development ��� Discovery, Preclinical, Clinical (Phase 1, Phase 2, and Phase 3) Main Service Areas: Bioanalytical, Preclinical SERVICES & CAPABILITIES: AAALAC accredited, multi-species in-vivo PK services, including CSF rodent collection, cComprehensive suite of ADMET in-vitro assays, discovery bioanalysis, featuring our Discovery 2.0��� methodology, experience in numerous biomarker assays, and GLP bioanalysis THERAPEUTIC AREAS: Oncology, ophthalmology, CNS, cardiovascular and infectious diseases, and medical devices ���We are thrilled that Agilux has been honored with the CRO Leadership Award in the categories of reliability, innovation, productivity, and regulatory. Following upon last year���s recognition, these awards reaffirm our dedication to building long-term relationships with our clients by continuing to provide ���Better Data Faster���. We are privileged to have the recognition of our industry colleagues, and I am gratified to accept this award on behalf of all the exceptional people at Agilux Laboratories.��� ��� Jim Jersey, Ph.D., co-founder, president & CEO 22 The CRO Leadership Awards 2013